IL119371A - 5, 6-disubstituted - 4-sulfonylaminopyrimidine -2- carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

5, 6-disubstituted - 4-sulfonylaminopyrimidine -2- carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL119371A
IL119371A IL11937196A IL11937196A IL119371A IL 119371 A IL119371 A IL 119371A IL 11937196 A IL11937196 A IL 11937196A IL 11937196 A IL11937196 A IL 11937196A IL 119371 A IL119371 A IL 119371A
Authority
IL
Israel
Prior art keywords
hydroxy
methoxy
signifies
phenoxy
alkyl
Prior art date
Application number
IL11937196A
Other languages
English (en)
Other versions
IL119371A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL119371A0 publication Critical patent/IL119371A0/xx
Publication of IL119371A publication Critical patent/IL119371A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11937196A 1995-10-12 1996-10-07 5, 6-disubstituted - 4-sulfonylaminopyrimidine -2- carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them IL119371A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH289395 1995-10-12

Publications (2)

Publication Number Publication Date
IL119371A0 IL119371A0 (en) 1997-01-10
IL119371A true IL119371A (en) 2001-04-30

Family

ID=4243971

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11937196A IL119371A (en) 1995-10-12 1996-10-07 5, 6-disubstituted - 4-sulfonylaminopyrimidine -2- carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (1) US5856484A (no)
EP (1) EP0768304B1 (no)
JP (1) JP2723496B2 (no)
CN (1) CN1115339C (no)
AR (1) AR004215A1 (no)
AT (1) ATE217867T1 (no)
AU (1) AU706748B2 (no)
BR (1) BR9605046B1 (no)
CA (1) CA2187130C (no)
CO (1) CO4770959A1 (no)
CZ (1) CZ260596A3 (no)
DE (1) DE59609225D1 (no)
DK (1) DK0768304T3 (no)
ES (1) ES2175006T3 (no)
HU (1) HUP9602748A3 (no)
IL (1) IL119371A (no)
MA (1) MA23980A1 (no)
MX (1) MX9604762A (no)
NO (1) NO308000B1 (no)
NZ (1) NZ299519A (no)
PE (1) PE17098A1 (no)
PL (1) PL316486A1 (no)
PT (1) PT768304E (no)
SG (1) SG46753A1 (no)
TR (1) TR199600778A2 (no)
TW (1) TW438779B (no)
UY (1) UY24346A1 (no)
ZA (1) ZA968451B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ260596A3 (en) * 1995-10-12 1997-12-17 Hoffmann La Roche Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof
JP4058507B2 (ja) 1997-07-10 2008-03-12 国立大学法人 東京医科歯科大学 ４，５−ジヒドロ−［１Ｈ］−ベンズ［ｇ］インダゾール−３−カルボン酸誘導体
US6191170B1 (en) 1998-01-13 2001-02-20 Tularik Inc. Benzenesulfonamides and benzamides as therapeutic agents
US6136971A (en) * 1998-07-17 2000-10-24 Roche Colorado Corporation Preparation of sulfonamides
CA2315614C (en) * 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles
JP2003518102A (ja) * 1999-12-22 2003-06-03 アクテリオン ファマシューティカルズ リミテッド ブチンジオール誘導体
US6720322B2 (en) 1999-12-22 2004-04-13 Actelion Pharamceuticals Ltd. Butyne diol derivatives
AU2001265871A1 (en) * 2000-04-25 2001-11-07 Actelion Pharmaceuticals Ltd Substituted sulfonylaminopyrimidines
US6387915B2 (en) 2000-05-31 2002-05-14 Pfizer Inc. Isoxazole-sulfonamide endothelin antagonists
US6670362B2 (en) 2000-09-20 2003-12-30 Pfizer Inc. Pyridazine endothelin antagonists
US8463964B2 (en) * 2009-05-29 2013-06-11 Invensys Systems, Inc. Methods and apparatus for control configuration with enhanced change-tracking

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW270116B (no) * 1991-04-25 1996-02-11 Hoffmann La Roche
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
TW287160B (no) * 1992-12-10 1996-10-01 Hoffmann La Roche
TW394761B (en) * 1993-06-28 2000-06-21 Hoffmann La Roche Novel Sulfonylamino Pyrimidines
IL111959A (en) * 1993-12-17 2000-07-16 Tanabe Seiyaku Co N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them
CZ260596A3 (en) * 1995-10-12 1997-12-17 Hoffmann La Roche Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof

Also Published As

Publication number Publication date
ES2175006T3 (es) 2002-11-16
AU706748B2 (en) 1999-06-24
AR004215A1 (es) 1998-11-04
EP0768304A1 (de) 1997-04-16
MA23980A1 (fr) 1997-07-01
UY24346A1 (es) 2001-03-16
TW438779B (en) 2001-06-07
DE59609225D1 (de) 2002-06-27
JP2723496B2 (ja) 1998-03-09
NO964334D0 (no) 1996-10-11
DK0768304T3 (da) 2002-09-09
NO308000B1 (no) 2000-07-03
US5856484A (en) 1999-01-05
CN1151400A (zh) 1997-06-11
NZ299519A (en) 1998-02-26
EP0768304B1 (de) 2002-05-22
CA2187130C (en) 2006-10-03
CA2187130A1 (en) 1997-04-13
SG46753A1 (en) 1998-02-20
MX9604762A (es) 1997-04-30
NO964334L (no) 1997-04-14
ZA968451B (en) 1997-04-14
PE17098A1 (es) 1998-04-15
PL316486A1 (en) 1997-04-14
PT768304E (pt) 2002-10-31
TR199600778A2 (tr) 1997-04-22
CN1115339C (zh) 2003-07-23
BR9605046B1 (pt) 2010-08-10
AU6817296A (en) 1997-04-17
HUP9602748A3 (en) 1998-04-28
CO4770959A1 (es) 1999-04-30
CZ260596A3 (en) 1997-12-17
HUP9602748A2 (en) 1997-05-28
BR9605046A (pt) 1998-06-30
JPH09110840A (ja) 1997-04-28
IL119371A0 (en) 1997-01-10
ATE217867T1 (de) 2002-06-15
HU9602748D0 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
JP4245130B2 (ja) 新規なスルファミド類
US5420129A (en) Phenylsulfonylamide pyrimidine
US5292740A (en) Sulfonamides
US5270313A (en) Sulfonamides and uses
CA2208018C (en) Sulfonamides
EP1137642B1 (en) Bis-sulfonamides
CA2187130C (en) Novel sulphonamides
US7091201B2 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
CA2162630C (en) Sulfonamides
JP4832706B2 (ja) 新規なアリールエテン−スルフォンアミド類
WO2001081335A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
PL198815B1 (pl) Pochodne 4-heterocyklilosulfonoamidylo-6-metoksy-5-(2-metoksyfenoksy)-2-pirydylopirymidyny, środek farmaceutyczny, zastosowanie pochodnych 4-heterocyklilosulfonoamidylo-6-metoksy-5-(2-metoksyfenoksy)-2-pirydylopirymidyny, ich wytwarzanie i związki pośrednie
US7323465B2 (en) Alkansulfonamides as endothelin antagonists
KR100521950B1 (ko) 설포닐아미노피리미딘
RU2173317C2 (ru) Сульфонамидные производные и фармацевтический препарат
EP1322624B1 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
EP1465875B1 (en) Novel alkansulfonamides as endothelin antagonists

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force